Contact Us   281-357-1881
nuru

Dr. S. Kemi

Nurudeen

Director of Fertility Preservation

BOARD CERTIFIED
Obstetrics and Gynecology
Reproductive Endocrinology and Infertility

281-357-1881

Dr. Nurudeen graduated magna cum laude from Texas A&M University and earned her medical degree from Texas A&M University Health Science Center College of Medicine. She completed a residency in Obstetrics and Gynecology at Georgetown University Hospital in Washington, D.C. where she was selected Chief Resident. Dr. Nurudeen went on to complete a fellowship in Reproductive Endocrinology and Infertility at the New York Presbyterian Hospital – Columbia University Medical Center in New York City.

During her fellowship, Dr. Nurudeen’s clinical research focused on diminished ovarian reserve, fertility preservation, oocyte donation, and reproduction issues among patients with medical conditions, such as viral infection and autoimmune disease. She also studied the age-dependent changes in molecular components and regulatory mechanisms involved in oocyte aging. She has authored several peer-reviewed publications and book chapters and has presented her research nationally and internationally. She has been the recipient of numerous scholarships, honors, and awards throughout her academic career and medical training.

Dr. Nurudeen is double board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. She is a member of the American College of Obstetrics and Gynecology, American Society for Reproductive Medicine, Society for Reproductive Endocrinology and Infertility, Houston Gynecological and Obstetrical Society, Houston Medical Forum and Mary Susan Moore Medical Society. She is the new Medical Director of the Sparkles of Life IVF Grant and has special interests in fertility preservation, diminished ovarian reserve, ovarian aging, and third party reproduction (egg donation and gestational carriers).

When helping patients reach their reproductive goals, Dr. Nurudeen strives for a holistic and personal touch through patient education, individualized care and top quality advanced medical technology.

Nurudeen S, Douglas N, Mahany E, Sauer M, Choi J. Fertility preservation decisions among newly diagnosedoncology patients: a single center experience. American Journal of Clinical Oncology. April 2016, 39(2): 154-159.

Sullivan-Pyke C, Nurudeen S, Grossman L, Sauer M, Douglas N. Fertility treatment options for HIV infectedindividuals. Future Virology; Aug 2013, (8): 1219-1231.

Nurudeen S, Grossman L, Bourne L, Guarnaccia M, Sauer M, Douglas N. Reproductive Outcomes of HIVSeropositive Women Treated by Assisted Reproduction. Journal of Women’s Health. Mar 2013, 22(3): 243-249.

Isgro J, Nurudeen S, Imundo L, Sauer M, Douglas N. Cyclophosphamide (CYC) Exposure in Pediatric Systemic LupusErythematous (pSLE) Is Associated With Reduced Serum Anti-mullerian (AMH) Hormone Levels. Journal ofRheumatology. Jun 2013, 40(6): 1029-1031.

Douglas N, Thornton M, Nurudeen S, Bucur M, Ferin M, Lobo R, Sauer M. Differential Expression of SerumGlycodelin and IGFBP-1 in Early Pregnancy. Reproductive Sciences. Nov 2013, 20(11): 1376-1381.

Nurudeen S, Levine B, Thornton M. Selecting and Screening Donors. In: M. Sauer (Ed.). Principles of Oocyte andEmbryo Donation. 2nd ed. New York, NY: Springer Publishing; 2012.

Levine B, Nurudeen S, Gosselin J, Sauer M. Addressing the fertility needs of HIV-seropositive males. Future Virology.March 2011, 6(3): 299-306

Levine B, Nurudeen S, Choi J, Sauer M. Ovarian Ectopic Pregnancy after Clomiphene Citrate and IntrauterineInsemination. Journal of Gynecologic Surgery. December 2011, 27(4): 267-269.

McCarthy-Keith D, Nurudeen S, Armstrong A, Levens E, Nieman LK. Recruitment and Retention of Women forClinical Leiomyoma Trials. [published online ahead of print Sept 27 2009]. Contemporary Clinical Trials. Jan 2010,31(1): 44-8.

Nurudeen S, Alford C, DeCherney A. Physiology of Reproduction in Women. In: DeCherney A, Goodwin T, Nathan L,Laufer N (Eds). Current Diagnosis and Treatment: Obstetrics and Gynecology. 11th ed. New York, NY: McGraw-Hill;2010.

Joseph DS, Malik M, Nurudeen S, Catherino WH. Myometrial cells undergo fibrotic transformation under theinfluence of transforming growth factor beta-3. Fertility Sterility. March 2010, 93(5): 1500-1508.

Browne H, Nurudeen S, Armstrong A, DeCherney A. Ethical and Psychological Considerations in FertilityPreservation Counseling. The Cancer Journal. Sept-Oct 2008. 14(5): 340-342.

Georgetown University Hospital Reproductive Endocrinology & Infertility Award

Georgetown University Hospital Maternal Fetal Medicine Award

Georgetown University Hospital OB/GYN Residency Training Program Administrative Chief Resident

Texas A&M University President’s Endowed Scholar

Texas A&M University Scholars Award

Texas A&M University Lettermen’s Award

Alpha Kappa Alpha National Academic Achievement Award

HOW TO GET STARTED

Schedule your first visit with Houston Fertility Institute. An HFI Fertility expert will sit down with you and answer any questions you may have, go over our process and discuss the best options for your fertility treatment. It really is that simple.

281.357.1881

aff-asrm
aff-fertile-hope
aff-resolve
aff-sart